Interferon-inducible protein 10 as a possible factor in the pathogenesis of cutaneous T-cell lymphomas

Clinical Cancer Research

Volumn 3, Issue 2, 1997, Pages 169-177

  Sarris, Andreas H ^a   Daliani, Danai ^a   Ulmer, Rose ^a   Crow, Mary ^a   Broxmeyer, Hal E ^b   Reiss, Michael ^c   Karasavvas, Nikos ^d   Zelenetz, Andrew D ^d   Pugh, William ^a   Cabanillas, Fernando ^a   Deisseroth, Albert B ^c   Duvic, Madeleine ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MALE; PRIORITY JOURNAL; SKIN TUMOR; T CELL LYMPHOMA;

ADULT; AGED; AGED, 80 AND OVER; CELL DIVISION; CHEMOKINE CXCL10; CHEMOKINES, CXC; CYTOKINES; FEMALE; HUMANS; INTERFERON TYPE II; INTERFERON-GAMMA; KERATINOCYTES; LYMPHOMA, T-CELL, CUTANEOUS; MALE; MIDDLE AGED; SKIN NEOPLASMS;

EID: 0031020442     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Hoppe, R. T., Wood, G. S., and Abel, E. A. Mycosis fungoides and the Sézary syndrome: pathology, staging, and treatment. Curr. Probl. Cancer, 14: 295-361, 1990.
2. Kaye, F. J., Bunn, P. J., Steinberg, S. M., Stocker, J. L., Ihde, D. C., Fischmann, A. B., Glaistein, E. J., Schlechter, G. P., Pheips, R. M., Foss, F. M., Parlette III, H. L., Anderson, M. J., and Sausville, E. A. A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides. N. Engl. J. Med., 321: 1784-1790, 1989.
3. Dmitrovsky, E., Matthews, M. J., Bunn, P. A., Schechter, G. P., Makuch, R. W., Winkler, C. F., Eddy, J., Sausville, E. A., and Ihde, D. C. Cytologic transformation in cutaneous T-cell tymphoma: a clinicopathologic entity associated with poor prognosis. J. Clin. Oncol., 5: 208-215, 1987.
4. Oppenheim, J. J., Zachariae, C. O., Mukaida, N., and Matsushima, K. Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu. Rev. Immunol., 9: 617-648, 1991.
5. Luster, A. D., Unkeless, J. C., and Ravetch, J. V. γ-Interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature (Lond.), 315: 672-676, 1985.
6. Narumi, S., and Hamilton, T. A. Inducible expression of murine IP-10 mRNA varies with the state of macrophage inflammatory activity. J. Immunol., 146: 3038-3044, 1991.
7. Gomez, C. M., Hamilton, T. A., Egido, J., and Emancipator, S. N. Expression of IP-10, a lipopolysaccharide- and interferon-γ-inducible protein, in murine mesangial cells in culture. Am. J. Pathol., 142: 433-439, 1993.
8. Ohmori, Y., and Hamilton, T. A. Cell type and stimulus-specific regulation of chemokine gene expression. Biochem. Biophys. Res. Commun., 198: 590-596, 1994.
9. Narumi, S., Wyner, L. M., Stoler, M. H., Tannenbaum, C. S., and Hamilton, T. A. Tissue-specific expression of murine IP-10 mRNA following systemic treatment with interferon-γ. J. Leukocyte Biol., 52: 27-33, 1992.
10. Ohmori, Y., Wyner, L., Narumi, S., Armstrong, D., Stoler, M., and Hamilton, T. A. Tumor necrosis factor a induces cell type and tissue-specific expression of chemoattractant cytokines in vivo. Am, J. Pathol., 142: 861-870, 1993.
11. Vanguri, P., and Farber, J. M. IFN and virus-inducible expression of an immediate early gene, crg-2/IP-10, and a delayed gene, I-Aα, in astrocytes and microglia. J. Immunol., 152: 1411-1418, 1994.
12. Sarris, A. H., Broxmeyer, H. E., Wirthmueller, U., Karasavvas, N., Cooper, S., Lu, L., Krueger, J., and Ravetch, J. V. Human interferon-inducible protein 10: expression and purification of recombinant protein demonstrate inhibition of early human hematopoietic progenitors. J. Exp. Med., 178: 1127-1132, 1993.
13. Sarris, A. H., Esgleyes-Ribot, T., Crow, M., Broxmeyer, H. E., Karasavvas, N., Pugh, W., Grossman, D., Deisseroth, A., and Duvic, M. Cytokine loops involving interteron-γ and IP-10, a cytokine chemotactic for CD4+ lymphocytes: an explanation for the epidermotropism of cutaneous T-cell lymphoma?, Blood, 86: 651-658, 1995.
14. Broxmeyer, H. E., Cooper, S., Hague, N., Benninger, L., Sarris, A., Cornetta, K., Vadhan-Raj, S., Hendrie, P., and Mantel, C. Human chemokines: enhancement of specific activity and effects in vitro on normal and leukemic progenitors and a factor-dependent cell line and in vivo in mice. Ann. Hematol., 71: 235-246, 1995.
15. Sarris, A. H., Talpaz, M., Deisseroth, A. B., and Estrov, Z. Human recombinant interferon-inducible protein 10 inhibits the proliferation of normal and acute myelogenous leukemia progenitors. Leukemia (Baltimore), 10: 757-765, 1996.
16. Aronica, S. M., Mantel, C., Gonin, R., Marshall, M. S., Sarris, A., Cooper, S., Hague, N., Zhang, X. F., and Broxmeyer, H. E. Interferon-inducible protein 10 and macrophage inflammatory protein 1α inhibit growth factor stimulation of Raf-1 kinase activity and protein synthesis in a human growth factor-dependent hematopoietic cell line. J. Biol. Chem., 270: 21998-22007, 1995.
17. Angiolillo, A. L., Sgadari, C., Taub, D. D., Liao, F., Farber, J. M., Maheshwari, S., Kleinman, H. K., Reaman, G. H., and Tosato, G. Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo. J. Exp. Med., 752: 155-162, 1995.
18. Taub, D. D., Lloyd, A. R., Conlon, K., Wang, J. M., Ortaldo, J. R., Harada, A., Matsushima, K., Kelvin, D. J., and Oppenheim, J. J. Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T-cell adhesion to endothelial cells. J. Exp. Med., 177: 1809-1814, 1993.
19. Taub, D. D., Longo, D. L., and Murphy, W. J. Human interferon-inducible protein 10 induces mononuclear cell infiltration in mice and promotes the migration of human T lymphocytes into the peripheral tissues of human peripheral blood lymphocytes-SCID mice. Blood. 87: 1423-1431, 1996.
20. Dewald, B., Moser, B., Barella, L., Schumacher, C., Baggiolini, M., and Clark, L. I. IP-10, a γ-interferon-inducible protein related to interleukin 8, lacks neutrophil-activating propenies. Immunol. Lett., 32: 81-84, 1992.
21. Proost, P., De Wolf-Peeters, C., Conings, R., Opdenakker, G., Billiau, A., and Van Damme, J. Identification of a novel granulocyte chemotactic protein (GCP-2) from human tumor cells. In vitro and in vivo comparison with natural forms of GRO, IP-10, and IL-8. J. Immunol., 750: 1000-1010, 1993.
22. Luster, A. D., and Leder, P. IP-10, a C-X-C chemokine, elicits a potent thymus-dependent amitumor response in vivo. J. Exp. Med., 178: 1057-1065, 1993.
23. Saed, G., Fiveson, D. P., Naidu, Y., and Nickoloff, B. J. Mycosis fungoides exhibits a Th1-type cell-mediated cytokine profile whereas Sézary syndrome expresses a Th2 profile. J. Invest. Dermatol., 103: 29-33, 1994.
24. Gottlieb, A. B., Luster, A. D., Posnett, D. N., and Carter, D. M. Detection of a γ-interferon-induced protein, IP-10, in psoriatic plaques. J. Exp. Med., 168: 941-948, 1988.
25. Studier, F. W., Rosenberg, A. H., Dunn, J. J., and Dubendorff, J. W. Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol., 185: 60-89, 1990.
26. Hochuli, E., Dobeli, H., and Schacher, A. New metal chelate adsorbent selective for proteins and peptides containing neighbouring histidine residues. J. Chromatogr., 411: 177-184, 1987.
27. Hochuli, E., Bannwarth, W., Döbeli, H., Gentz, R., and Stüber, D. Genetic approach to facilitate purification of recombinant proteins with a novel metal chelate adsorbent. Bio/Technology, 6: 1321-1325, 1988.
28. Cabanillas, F., Armitage, J., Pugh, W. C., Weisenburger, D., and Duvic, M. Lymphomatoid papulosis; a T-cell dyscrasia with a propensity to transform into malignant lymphoma. Ann. Intern. Med., 122: 210-217, 1995.
29. Sausville, E. A., Eddy, J. L., Makuch, R. W., Fischmann, A. B., Schechter, G. P., Matthews, M., Glatstein, E., Ihde, D. C., Kaye, F., Veach, S. R., Phelps, R., O'Connor, T., Trepel, J. B., Cotelingam, J. D., Gazdar, A. F., Minna, J. D., and Bunn, P. A., Jr. Histopathologic staging at initial diagnosis of mycosis fungoides and the Sézary syndrome. Definition of three distinctive prognostic groups. Ann. Intern. Med., 109: 372-382, 1988.
30. Reiss, M., and Sartorelli, A. C. Regulation of growth and differentiation of human keratinocytes by type β transforming growth factor and epidermal growth factor. Cancer Res., 47: 6705-6709, 1987.
31. Pirisi, L., Yasumoto, S., Feller, M., Doniger, J., and Di, P. J. Transformation of human fibroblasts and keratinocytes with human papillomavirus type 16 DNA. J. Virol., 61: 1061-1066, 1987.
32. Taub, D. D., Conlon, K., Lloyd, A. R., Oppenheim, J. J., and Kelvin, D. J. Preferential migration of activated CD4 + and CD8+ T cells in response to MIP-1α and MIP-1β. Science (Washington DC), 260: 355-358, 1993.
33. Luster, A. D., and Ravetch, J. V. Biochemical characterization of a γ-mterferon-inducible cytokine (IP-10). J. Exp. Med., 166: 1084-1097, 1987.
34. Parkinson, E. K., Graham, G. J., Daubersies, P., Burns, J. E., Heufler, C., Plumb, M., Schuler, G., and Pragnell, I. B. Hemopoietic stem cell inhibitor (SCI/MIP-1α) also inhibits clonogenic epidermal keratinocyte proliferation. J. Invest. Dermatol., 101: 113-117, 1993.
35. Springer, T. A. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell, 76: 301-314, 1994.
36. Mackay, C. R. Migration pathways and immunologie memory among T lymphocytes. Semin. Immunol., 4: 51-58, 1992.
37. Jackow, C. M., Gather, J., Hearne, V., Asano, A. T., Musser, J., and Duvic, M. Association of erythrodermic cutaneous T-cell lymphoma, superantigen-positive Staphylococcus aureus, and oligoclonal T-cell receptor Vβ gene expression. Blood, in press, 1997.
38. Tanaka, Y., Adams, D. H., Hubscher, S., Hirano, H., Siebenlist, U., and Shaw, S. T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1β. Nature (Lond.), 361: 79-82, 1993.
39. Vowels, B. R., Cassin, M., Vonderheid, E. C., and Rook, A. H. Aberrant cytokine production by Sezary syndrome patients: cytokine secretion pattern resembles murine Th2 cells. J. Invest. Dermatol., 99: 90-94, 1992.
40. Nickoloff, B. J., Griffiths, C. E., Baadsgaard, O., Voorhees, J. J., Hanson, C. A., and Cooper, K. D. Markedly diminished epidermal keratinocyte expression of intercellular adhesion molecule 1 (ICAM-10 in Sézary syndrome. J. Am. Med. Assoc., 267: 2217-2221, 1989.
41. Hansen, E. R., Vejlsgaard, G. L., Lisby, S., Heidenheim, M., and Baadsgaard, O. Epidermal interleukin 1α functional activity and interleukin 8 immunoreactivity are increased in patients with cutaneous T-cell lymphoma. J. Invest. Dermatol., 97: 818-823, 1991.
42. Daliani, D., Jackow, C. M., Sarris, A. H., and Duvic, M. Interferon-inducible protein 10 is expressed in cutaneous T-cell lymphoma lesions associated with cytokines TNF-α and IFN-γ in the absence of detectable HTLV-I Pol or tax proviral mRNA sequences. In: VI International Conference on Malignant Lymphoma, p. 133. Lugano. Switzerland: F. Cavalli, 1996.
43. Griffiths, C. E., Voorhees, J. J., and Nickoloff, B. J. Characterization of intercellular adhesion molecule 1 and HLA-DR expression in normal and inflamed skin: modulation by recombinant γ-interferon and tumor necrosis factor. J. Am. Acad. Dermatol., 20: 617-629, 1989.
44. Grassmann, R., Berchtold, S., Radant, I., Alt, M., Fleckenstein, B., Sodroski, J. G., Haseltine, W. A., and Ramstedt, U. Role of human T-cell leukemia virus type 1 X region proteins in immortalization of primary human lymphocytes in culture. J. Virol., 66: 4570-4575, 1992.
45. Brown, D. A., Nelson, F. B., Reinherz, E. L., and Diamond, D. J. The human interferon-γ gene contains an inducible promoter that can be transactivated by tax I and II. Eur. J. Immunol., 21: 1879-1885, 1991.
46. Tatewaki, M., Yamaguchi, K., Masao, M., Ishii, T., Miyasaka, M., Mori, S., Takachuki, K., and Watanabe, T. Constitutive overexpression of the L-selectin gene in fresh leukemic cells of adult T-cell leukemia that can be transactivated by human T-cell lymphotropic virus type 1 tax. Blood, 86: 3109-3117, 1985.
47. Pancake, B. A., and Zucker, F. D. "HTLV tax and mycosis fungoides" (Letter). N. Engl. J. Med., 329: 580, 1993.
48. Ghosh, S. K., Abrams, J. T., Terunuma, H., Vonderheid, E. C., and DeFreitas, E. Human T-cell leukemia virus type I tax/rex DNA and RNA in cutaneous T-cell lymphoma. Blood, 84: 2663-2671, 1994.
49. Manca, N., Piacentini, E., Gelmi, M., Calzavara, P., Manganoni, M. A., Glukhov, A., Gargiulo, F., De Francesco, M., Pirali, F., De Panfilis, G., and Turano, A. Persistence of human T-cell lymphotropic virus type 1 (HTLV-1) sequences in peripheral blood mononuclear cells from patients with mycosis fungoides. J. Exp. Med., 180: 1973-1978, 1994.
50. Pancake, B. A., Zucker-Franklin, D., and Coutavas, E. E. The cutaneous T-cell lymphoma, mycosis fungoides, is a human T-cell lymphotropic virus-associated disease. A study of 50 patients. J. Clin. Invest., 95: 547-554, 1995.
51. Sarris, A., Ulmer, R., Daliani, D., Jackow, C., and Duvic, M. Interferon-inducible protein 10, TNF-α and TNF-γ are co-expressed in cutaneous T-cell lymphoma lesions. J. Invest. Dermatol., 106: 837, 1996.